Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/67257
Registo completo
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Malhone, Carolina | por |
dc.contributor.author | Longatto, Adhemar | por |
dc.date.accessioned | 2020-10-02T14:00:38Z | - |
dc.date.issued | 2019-08 | - |
dc.identifier.issn | 0887-2171 | - |
dc.identifier.uri | https://hdl.handle.net/1822/67257 | - |
dc.description.abstract | Tumors markers can be described as molecular products expressed by neoplasia tissues (immunohistochemistry), or metabolized and secreted by tumor and characterized biochemically in body fluids such as blood and urine. They may have utility as indicators of tumor stage and grade as well useful for monitoring responses to treatment and predicting recurrence, progression, development of metastases, or even patient survival. Unfortunately, in some cases they may have no identified clinical potential. Several investigations have been carried out, especially in the last decade, using biotechnological methods, in order to identify new potential tumor markers. By translating these findings into clinical use one may facilitate accurate diagnosis and prognostic prediction, and contribute to individualized treatment. The objective of this review is to describe some biomarkers with potential use in clinical settings of uterine cervix, ovary, and endometrium carcinomas. | por |
dc.language.iso | eng | por |
dc.publisher | Elsevier 1 | por |
dc.rights | restrictedAccess | por |
dc.subject | Antigens, Neoplasm | por |
dc.subject | Biomarkers, Tumor | por |
dc.subject | Circulating Tumor DNA | por |
dc.subject | Endometrial Neoplasms | por |
dc.subject | Female | por |
dc.subject | Genes, p16 | por |
dc.subject | Humans | por |
dc.subject | Ki-67 Antigen | por |
dc.subject | Membrane Proteins | por |
dc.subject | MicroRNAs | por |
dc.subject | RNA-Binding Proteins | por |
dc.subject | Uterine Cervical Neoplasms | por |
dc.subject | WAP Four-Disulfide Core Domain Protein 2 | por |
dc.title | Cervical, ovarian and endometrial tumor markers: potential clinical value | por |
dc.type | article | por |
dc.peerreviewed | yes | por |
oaire.citationStartPage | 350 | por |
oaire.citationEndPage | 357 | por |
oaire.citationIssue | 4 | por |
oaire.citationVolume | 40 | por |
dc.identifier.doi | 10.1053/j.sult.2019.03.003 | por |
dc.date.embargo | 10000-01-01 | - |
dc.identifier.pmid | 31375174 | por |
dc.subject.wos | Science & Technology | por |
sdum.journal | Seminars in Ultrasound, CT and MRI | por |
Aparece nas coleções: | ICVS - Artigos em revistas internacionais / Papers in international journals |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Malhone-2019-Cervical-ovarian-and-endometrial-tu.pdf Acesso restrito! | 380,06 kB | Adobe PDF | Ver/Abrir |